Thinner and Solvent for industrial use

Hazard statements (CLP)

H315, H319, H351, H411

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

May cause drowsiness or dizziness. Causes serious eye irritation. Toxic to aquatic life with long lasting effects. Suspected of causing cancer Causes skin irritation

Hazard pictograms

GHS07 GHS08 GHS09

Signal word

Warning

Contains

dichloromethane; methylene chloride

Hazard statements

H315 - Causes skin irritation. H319 - Causes serious eye irritation. H351 - Suspected of causing cancer. H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

P201 - Obtain special instructions before use. P264 - Wash hands, forearms and face thoroughly after handling. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P308+P313 - IF exposed or concerned: Get medical advice/attention. P321 - Specific treatment (see supplemental first aid instruction on this label). P391 - Collect spillage.

Additional information

Restricted to industrial use and to professionals approved in certain EU Member States – verify where use is allowed.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component dichloromethane; methylene chloride(75-09-2) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Carcinogenicity, Category 2 H351 Hazardous to the aquatic environment – Chronic Hazard, Category 2 H411 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause drowsiness or dizziness. Causes serious eye irritation. Toxic to aquatic life with long lasting effects. Suspected of causing cancer. Causes skin irritation.